PDX Models Market | Global Market Revenue Expected to Grow at a CAGR of 16.7%Posted by Dheeraj Shaha on January 13th, 2020 The key factors driving the growth of this market include the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. The growing use of humanized PDX models is posing a lucrative opportunity in this market. Get Crucial Industry Insights | Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121598251 On the basis of tumor type, the PDX Models Market has been segmented into gastrointestinal tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, hematological tumor models, and other tumor models such as head & neck tumors, sarcoma, and melanoma. In 2017, the gastrointestinal tumors segment is expected to account for the largest share of the global PDx Models Market. The respiratory tumors segment, on the other hand, is expected to be the fastest-growing segment during the forecast period. Growth in this segment is mainly driven by the increasing focus of market players on generating lung cancer PDX models, which could lead to a breakthrough in lung cancer treatment as lung cancer is the leading cause of cancer-related deaths across the globe. By application, the preclinical drug development and basic cancer research held the largest market share in 2017 Based on application, the PDx Models Market is further segmented into the preclinical drug development & basic cancer research and biomarker analysis. In 2017, the preclinical drug development and basic cancer research segment is expected to account for the largest share of the global PDx Models Market. The large share of this segment can be mainly attributed to the increasing number of research activities in the field of oncology drug research. North America dominated the market in 2017 North America accounted for the largest share of the PDx Models Market in 2017, followed by Europe. The large share of the North American PDx Models Market can be attributed to the growth in biomedical research in the US, rising preclinical activities by CROs and pharmaceutical companies, and growing stem cell research in Canada. However, the Asia Pacific market is projected to grow at the highest CAGR during the forecast period, owing to strong research expenditure and the well-structured CRO industry in China, growth in biomedical & medical research in Japan, rising pharmaceutical R&D expenditure in India, and rising translational and biomedical research in Singapore. Like it? Share it!More by this author |